240 related articles for article (PubMed ID: 20601272)
1. Proteomics of colorectal cancer: overview of discovery studies and identification of commonly identified cancer-associated proteins and candidate CRC serum markers.
Jimenez CR; Knol JC; Meijer GA; Fijneman RJ
J Proteomics; 2010 Sep; 73(10):1873-95. PubMed ID: 20601272
[TBL] [Abstract][Full Text] [Related]
2. Mass spectrometry based translational proteomics for biomarker discovery and application in colorectal cancer.
Ma H; Chen G; Guo M
Proteomics Clin Appl; 2016 Apr; 10(4):503-15. PubMed ID: 26616366
[TBL] [Abstract][Full Text] [Related]
3. Identification of Differentially Expressed Proteins in the Serum of Colorectal Cancer Patients Using 2D-DIGE Proteomics Analysis.
Lim LC; Looi ML; Zakaria SZ; Sagap I; Rose IM; Chin SF; Jamal R
Pathol Oncol Res; 2016 Jan; 22(1):169-77. PubMed ID: 26463353
[TBL] [Abstract][Full Text] [Related]
4. The cancer secretome, current status and opportunities in the lung, breast and colorectal cancer context.
Schaaij-Visser TB; de Wit M; Lam SW; Jiménez CR
Biochim Biophys Acta; 2013 Nov; 1834(11):2242-58. PubMed ID: 23376433
[TBL] [Abstract][Full Text] [Related]
5. Use of multiple reaction monitoring for multiplex analysis of colorectal cancer-associated proteins in human feces.
Ang CS; Rothacker J; Patsiouras H; Gibbs P; Burgess AW; Nice EC
Electrophoresis; 2011 Aug; 32(15):1926-38. PubMed ID: 21538981
[TBL] [Abstract][Full Text] [Related]
6. Colorectal cancer biomarker discovery and validation using LC-MS/MS-based proteomics in blood: truth or dare?
Reumer A; Maes E; Mertens I; Cho WC; Landuyt B; Valkenborg D; Schoofs L; Baggerman G
Expert Rev Proteomics; 2014 Aug; 11(4):449-63. PubMed ID: 24702250
[TBL] [Abstract][Full Text] [Related]
7. Mass Spectrometry-Based Analysis for the Discovery and Validation of Potential Colorectal Cancer Stool Biomarkers.
Ang CS; Baker MS; Nice EC
Methods Enzymol; 2017; 586():247-274. PubMed ID: 28137566
[TBL] [Abstract][Full Text] [Related]
8. Quantitative proteomic analysis exploring progression of colorectal cancer: Modulation of the serpin family.
Peltier J; Roperch JP; Audebert S; Borg JP; Camoin L
J Proteomics; 2016 Oct; 148():139-48. PubMed ID: 27492143
[TBL] [Abstract][Full Text] [Related]
9. Cell surface proteomics identifies glucose transporter type 1 and prion protein as candidate biomarkers for colorectal adenoma-to-carcinoma progression.
de Wit M; Jimenez CR; Carvalho B; Belien JA; Delis-van Diemen PM; Mongera S; Piersma SR; Vikas M; Navani S; Pontén F; Meijer GA; Fijneman RJ
Gut; 2012 Jun; 61(6):855-64. PubMed ID: 21890811
[TBL] [Abstract][Full Text] [Related]
10. An integrated proteomics and metabolomics approach for defining oncofetal biomarkers in the colorectal cancer.
Ma Y; Zhang P; Wang F; Liu W; Yang J; Qin H
Ann Surg; 2012 Apr; 255(4):720-30. PubMed ID: 22395091
[TBL] [Abstract][Full Text] [Related]
11. Serum proteome analysis for profiling protein markers associated with lymph node metastasis in colorectal carcinoma.
Zhao L; Liu Y; Sun X; Peng K; Ding Y
J Comp Pathol; 2011; 144(2-3):187-94. PubMed ID: 21074777
[TBL] [Abstract][Full Text] [Related]
12. [Biomarker Discovery of Colorectal Cancer Using Membrane Proteins Extracted from Cancer Tissues].
Tomonaga T; Kume H
Rinsho Byori; 2015 Mar; 63(3):322-7. PubMed ID: 26524855
[TBL] [Abstract][Full Text] [Related]
13. Proteomics for discovery of candidate colorectal cancer biomarkers.
Alvarez-Chaver P; Otero-Estévez O; Páez de la Cadena M; Rodríguez-Berrocal FJ; Martínez-Zorzano VS
World J Gastroenterol; 2014 Apr; 20(14):3804-24. PubMed ID: 24744574
[TBL] [Abstract][Full Text] [Related]
14. Detection of cadherin-17 in human colon cancer LIM1215 cell secretome and tumour xenograft-derived interstitial fluid and plasma.
Bernhard OK; Greening DW; Barnes TW; Ji H; Simpson RJ
Biochim Biophys Acta; 2013 Nov; 1834(11):2372-9. PubMed ID: 23557862
[TBL] [Abstract][Full Text] [Related]
15. Novel proteomic strategy reveal combined alpha1 antitrypsin and cathepsin D as biomarkers for colorectal cancer early screening.
Xie LQ; Zhao C; Cai SJ; Xu Y; Huang LY; Bian JS; Shen CP; Lu HJ; Yang PY
J Proteome Res; 2010 Sep; 9(9):4701-9. PubMed ID: 20666480
[TBL] [Abstract][Full Text] [Related]
16. Discovery of melanotransferrin as a serological marker of colorectal cancer by secretome analysis and quantitative proteomics.
Shin J; Kim HJ; Kim G; Song M; Woo SJ; Lee ST; Kim H; Lee C
J Proteome Res; 2014 Nov; 13(11):4919-31. PubMed ID: 25216327
[TBL] [Abstract][Full Text] [Related]
17. Murine fecal proteomics: a model system for the detection of potential biomarkers for colorectal cancer.
Ang CS; Rothacker J; Patsiouras H; Burgess AW; Nice EC
J Chromatogr A; 2010 May; 1217(19):3330-40. PubMed ID: 19875126
[TBL] [Abstract][Full Text] [Related]
18. Plasma clusterin as a candidate pre-diagnosis marker of colorectal cancer risk in the Florence cohort of the European Prospective Investigation into Cancer and Nutrition: a pilot study.
Bertuzzi M; Marelli C; Bagnati R; Colombi A; Fanelli R; Saieva C; Ceroti M; Bendinelli B; Caini S; Airoldi L; Palli D
BMC Cancer; 2015 Feb; 15():56. PubMed ID: 25884309
[TBL] [Abstract][Full Text] [Related]
19. Gel-Based Proteomics of Clinical Samples Identifies Potential Serological Biomarkers for Early Detection of Colorectal Cancer.
Thorsen SF; Gromova I; Christensen IJ; Fredriksson S; Andersen CL; Nielsen HJ; Stenvang J; Moreira JMA
Int J Mol Sci; 2019 Dec; 20(23):. PubMed ID: 31810358
[TBL] [Abstract][Full Text] [Related]
20. Secretome Proteomic Approaches for Biomarker Discovery: An Update on Colorectal Cancer.
Cevenini A; Orrù S; Imperlini E
Medicina (Kaunas); 2020 Aug; 56(9):. PubMed ID: 32878319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
